Risk factors for development of paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pleural tuberculosis

Tohoku Journal of Experimental Medicine

Volumn 223, Issue 3, 2011, Pages 199-204

  Jung, Jae Woo ^a   Shin, Jong Wook ^a   Kim, Jae Yeol ^a   Park, In Won ^a   Choi, Byoung Whui ^a   Seo, Jae Seung ^a   Choi, Jae Chol ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Hiv seronegativity; Paradoxical response; Pleurisy; Risk factors; Tuberculosis

Indexed keywords

ALBUMIN; ETHAMBUTOL; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DETERIORATION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DYSPNEA; FEMALE; HUMAN; INCIDENCE; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SKIN MANIFESTATION; SOUTH KOREA; THORACOTOMY; THORAX DRAINAGE; TREATMENT OUTCOME; TUBERCULOUS PLEURISY;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE; FEMALE; HIV SERONEGATIVITY; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; REPUBLIC OF KOREA; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PLEURAL;

EID: 79952415115     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.223.199     Document Type: Article

References (30)

1. Afghani, B. & Lieberman, J.M. (1994) Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin. Infect. Dis., 19, 1092-1099.
2. Al-Majed, S.A. (1996) Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir. Med., 90, 211-214.
3. Bass, J.B. Jr., Farer, L.S., Hopewell, P.C., O'Brien, R., Jacobs, R.F., Ruben, F., Snider, D.E. Jr. & Thornton, G. (1994) Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am. J. Respir. Crit. Care Med., 149, 1359-1374.
4. Batungwanayo, J., Taelman, H., Allen, S., Bogaerts, J., Kagame, A. & Van de Perre, P. (1993) Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda. AIDS, 7, 73-79.
5. Baumann, M.H., Nolan, R., Petrini, M., Lee, Y.C., Light, R.W. & Schneider, E. (2007) Pleural tuberculosis in the United States: incidence and drug resistance. Chest, 131, 1125-1132.
6. Berger, H.W. & Mejia, E. (1973) Tuberculous pleurisy. Chest, 63, 88-92.
7. Breen, R.A., Smith, C.J., Bettinson, H., Dart, S., Bannister, B., Johnson, M.A. & Lipman, M.C. (2004) Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax, 59, 704-707.
8. Chambers, S.T., Hendrickse, W.A., Record, C., Rudge, P. & Smith, H. (1984) Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet, 2, 181-184.
9. Cheng, S.L., Wang, H.C. & Yang, P.C. (2007) Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis., 11, 1290-1295.
10. Cheng, V.C., Ho, P.L., Lee, R.A., Chan, K.S., Chan, K.K., Woo, P.C., Lau, S.K. & Yuen, K.Y. (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis., 21, 803-809.
11. Cheng, V.C., Yam, W.C., Woo, P.C., Lau, S.K., Hung, I.F., Wong, S.P., Cheung, W.C. & Yuen, K.Y. (2003) Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur. J. Clin. Microbiol. Infect. Dis., 22, 597-602.
12. Cho, O.H., Park, K.H., Kim, T., Song, E.H., Jang, E.Y., Lee, E.J., Chong, Y.P., Choi, S.H., Lee, S.O., Woo, J.H., Kim, Y.S. & Kim, S.H. (2009) Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J. Infect., 59, 56-61.
13. Choi, Y.W., Jeon, S.C., Seo, H.S., Park, C.K., Park, S.S., Hahm, C.K. & Joo, K.B. (2002) Tuberculous pleural effusion: new pulmonary lesions during treatment. Radiology, 224, 493-502.
14. DeSimone, J.A., Pomerantz, R.J. & Babinchak, T.J. (2000) Infam-matory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann. Intern. Med., 133, 447-454.
15. Dutt, A.K., Moers, D. & Stead, W.W. (1986) Short-course chemotherapy for pleural tuberculosis. Nine years' experience in routine treatment service. Chest, 90, 112-116.
16. Ferrer Sancho, J. (1996) Pleural tuberculosis: incidence, pathogen-esis, diagnosis & treatment. Curr. Opin. Pulm. Med., 2, 327-334.
17. Gopi, A., Madhavan, S.M., Sharma, S.K. & Sahn, S.A. (2007) Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest, 131, 880-889.
18. Grange, J.M., Stanford, J.L. & Rook, G.A. (1995) Tuberculosis and cancer: parallels in host responses and therapeutic approaches? Lancet, 345, 1350-1352.
19. Hejazi, N. & Hassler, W. (1997) Multiple intracranial tubercu-lomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Infection, 25, 233-239.
20. Kim, D.H., Kim, H.J., Park, S.K., Kong, S.J., Kim, Y.S., Kim, T.H., Kim, E.K., Lee, K.M., Lee, S.S., Park, J.S., Koh, W.J., Lee, C.H. & Shim, T.S. (2010) Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med., 182, 113-119.
21. Kim, H.J., Lee, H.J., Kwon, S.Y., Yoon, H.I., Chung, H.S., Lee, C.T., Han, S.K., Shim, Y.S. & Yim, J.J. (2006) The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest, 129, 1253-1258.
22. Kumar, R. & Vasu, T.S. (2001) Paradoxical response to chemotherapy in tuberculous pleural effusion. Saudi. Med. J., 22, 812-813.
23. Lin, M.T., Wang, J.Y., Yu, C.J., Lee, L.N. & Yang, P.C. (2009) Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers. Respir. Med., 103, 820-826.
24. Marshall, B.G. & Chambers, M.A. (1998) Central nervous system tuberculosis-the paradox of the host immune response. J. Infect., 36, 3-4.
25. Navas, E., Martin-Davila, P., Moreno, L., Pintado, V., Casado, J.L., Fortun, J., Perez-Elias, M.J., Gomez-Mampaso, E. & Moreno, S. (2002) Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch. Intern. Med., 162, 97-99.
26. Seibert, A.F., Haynes, J. Jr., Middleton, R. & Bass, J.B. Jr. (1991) Tuberculous pleural effusion. Twenty-year experience. Chest, 99, 883-886.
27. Smith, H. (1987) Paradoxical responses during the chemotherapy of tuberculosis. J. Infect., 15, 1-3.
28. Toossi, Z., Young, T.G., Averill, L.E., Hamilton, B.D., Shiratsuchi, H. & Ellner, J.J. (1995) Induction of transforming growth factor beta 1 by purifed protein derivative of Mycobacterium tuberculosis. Infect. Immun., 63, 224-228.
29. Tostmann, A., Boeree, M.J., Aarnoutse, R.E., de Lange, W.C., van der Ven, A.J. & Dekhuijzen, R. (2008) Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J. Gastro-enterol. Hepatol., 23, 192-202.
30. Wendel, K.A., Alwood, K.S., Gachuhi, R., Chaisson, R.E., Bishai, W.R. & Sterling, T.R. (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest, 120, 193-197.